Subtopic Deep Dive
Immunotherapy for Animal Mycoses
Research Guide
What is Immunotherapy for Animal Mycoses?
Immunotherapy for animal mycoses encompasses cytokine therapies and monoclonal antibodies developed as adjuncts to antifungals for treating invasive fungal infections in veterinary patients.
This subtopic focuses on enhancing host immune responses against pathogens like Aspergillus fumigatus and Pythium insidiosum in animals. Key studies explore vaccines and immunopharmacology in immunocompromised hosts (Cutler et al., 2006; 221 citations; Mendoza and Newton, 2005; 123 citations). Over 10 papers from the list address related immunology and treatment models.
Why It Matters
Immunotherapy addresses refractory systemic mycoses in veterinary medicine where antifungals alone fail, improving survival in animals with pythiosis and aspergillosis (Mendoza and Newton, 2005; Krajaejun et al., 2006; 247 citations). Animal models validate these approaches for translation to clinical use (Capilla et al., 2007; 91 citations). Ben-Ami et al. (2008; 136 citations) show modern antifungals interact with host immunity, amplifying immunotherapy effects in high-risk patients.
Key Research Challenges
Limited Veterinary-Specific Data
Most immunotherapy studies target human mycoses, leaving animal models underdeveloped for species like dogs and horses (Capilla et al., 2007). Translation from human cohorts faces gaps in fungal strain specificity (Lionakis and Levitz, 2017; 195 citations).
Immunosuppression Variability
Veterinary patients vary in immune status, complicating cytokine dosing and monoclonal antibody efficacy (Ben-Ami et al., 2008). Pythium insidiosum resists standard antifungals, demanding tailored adjuncts (Mendoza and Newton, 2005).
Antifungal Adjunct Optimization
Combining immunotherapies with antifungals risks immune overactivation or inefficacy (Rogers, 2007; 179 citations). Animal models reveal inconsistent outcomes across infection models (Sugui et al., 2014; 268 citations).
Essential Papers
Aspergillus fumigatus and Related Species
Janyce A. Sugui, K. J. Kwon-Chung, Praveen R. Juvvadi et al. · 2014 · Cold Spring Harbor Perspectives in Medicine · 268 citations
The genus Aspergillus contains etiologic agents of aspergillosis. The clinical manifestations of the disease range from allergic reaction to invasive pulmonary infection. Among the pathogenic asper...
Clinical and Epidemiological Analyses of Human Pythiosis in Thailand
Theerapong Krajaejun, Boonmee Sathapatayavongs, Roongnapa Pracharktam et al. · 2006 · Clinical Infectious Diseases · 247 citations
Here, we report, to our knowledge, the largest case study of human pythiosis. The disease has high rates of morbidity and mortality. Early diagnosis and effective treatment are urgently needed to i...
Advances in combating fungal diseases: vaccines on the threshold
Jim E. Cutler, George S. Deepe, Bruce S. Klein · 2006 · Nature Reviews Microbiology · 221 citations
Host Control of Fungal Infections: Lessons from Basic Studies and Human Cohorts
Michail S. Lionakis, Stuart M. Levitz · 2017 · Annual Review of Immunology · 195 citations
In the last few decades, the AIDS pandemic and the significant advances in the medical management of individuals with neoplastic and inflammatory conditions have resulted in a dramatic increase in ...
Treatment of zygomycosis: current and new options
Thomas R. Rogers · 2007 · Journal of Antimicrobial Chemotherapy · 179 citations
Zygomycosis is a frequently lethal invasive infection in high-risk patients such as the immunocompromised [especially haematopoietic stem cell transplant (HSCT) recipients] and patients with type 2...
Epidemiology and treatment approaches in management of invasive fungal infections
James I. Ito, Kriengkauykiat, Sanjeet Dadwal et al. · 2011 · Clinical Epidemiology · 154 citations
Over the past 20 years, the number of invasive fungal infections has continued to persist, due primarily to the increased numbers of patients subjected to severe immunosuppression. Despite the deve...
Immunocompromised Hosts: Immunopharmacology of Modern Antifungals
Ronen Ben‐Ami, Russell E. Lewis, Dimitrios P. Kontoyiannis · 2008 · Clinical Infectious Diseases · 136 citations
In addition to their in vitro inhibitory and fungicidal effects, modern antifungal agents interact in vivo with host immune functions involved in defense against fungal pathogens. The nature of suc...
Reading Guide
Foundational Papers
Start with Sugui et al. (2014; 268 citations) for Aspergillus pathology and Cutler et al. (2006; 221 citations) for vaccine foundations, as they establish fungal immunology basics translatable to animals.
Recent Advances
Study Lionakis and Levitz (2017; 195 citations) for host control advances and Santúrio et al. (2018; 100 citations) for emerging pythiosis insights.
Core Methods
Core techniques: animal infection models (Capilla et al., 2007), immunopharmacology assays (Ben-Ami et al., 2008), and epidemiological cohort analysis (Krajaejun et al., 2006).
How PapersFlow Helps You Research Immunotherapy for Animal Mycoses
Discover & Search
Research Agent uses searchPapers and exaSearch to find immunotherapy papers like 'Immunology and immunotherapy of the infections caused by Pythium insidiosum' by Mendoza and Newton (2005), then citationGraph reveals connections to animal models in Capilla et al. (2007). findSimilarPapers expands to vaccine advances (Cutler et al., 2006).
Analyze & Verify
Analysis Agent applies readPaperContent to extract immunotherapy protocols from Lionakis and Levitz (2017), verifies claims with CoVe against Ben-Ami et al. (2008), and uses runPythonAnalysis for survival curve meta-analysis via pandas on citation data. GRADE grading assesses evidence strength for veterinary translation.
Synthesize & Write
Synthesis Agent detects gaps in animal-specific monoclonal antibody trials, flags contradictions between human and vet data. Writing Agent employs latexEditText for manuscript drafting, latexSyncCitations for 10+ papers, latexCompile for figures, and exportMermaid for immunotherapy pathway diagrams.
Use Cases
"Analyze survival rates in pythiosis immunotherapy animal models"
Research Agent → searchPapers('pythiosis immunotherapy animals') → Analysis Agent → readPaperContent(Mendoza 2005) → runPythonAnalysis(pandas meta-analysis of survival data) → GRADE-graded report with stats.
"Draft LaTeX review on Aspergillus immunotherapy in vets"
Synthesis Agent → gap detection(Sugui 2014 + Cutler 2006) → Writing Agent → latexEditText(intro) → latexSyncCitations(10 papers) → latexCompile → PDF with antifungal-immunotherapy table.
"Find code for fungal infection simulation models"
Research Agent → searchPapers('mycoses animal models simulation') → Code Discovery → paperExtractUrls(Capilla 2007) → paperFindGithubRepo → githubRepoInspect → executable Python model for immunotherapy testing.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers(50+ mycoses papers) → citationGraph → DeepScan(7-step verification with CoVe on immunotherapy efficacy). Theorizer generates hypotheses on cytokine synergies from Krajaejun et al. (2006) and Rogers (2007). DeepScan analyzes pythiosis immunology checkpoints.
Frequently Asked Questions
What defines immunotherapy for animal mycoses?
It involves cytokine therapy and monoclonal antibodies as adjuncts to antifungals for veterinary fungal infections like aspergillosis and pythiosis (Mendoza and Newton, 2005).
What are key methods in this subtopic?
Methods include animal models for vaccine testing (Capilla et al., 2007) and immunopharmacology studies (Ben-Ami et al., 2008).
What are major papers?
Top papers: Sugui et al. (2014; 268 citations) on Aspergillus; Mendoza and Newton (2005; 123 citations) on Pythium immunotherapy; Cutler et al. (2006; 221 citations) on vaccines.
What open problems exist?
Challenges include veterinary data scarcity and optimizing adjuncts in immunosuppressed animals (Lionakis and Levitz, 2017; Rogers, 2007).
Research Infectious Diseases and Mycology with AI
PapersFlow provides specialized AI tools for Veterinary researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
AI Academic Writing
Write research papers with AI assistance and LaTeX support
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Immunotherapy for Animal Mycoses with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Veterinary researchers
Part of the Infectious Diseases and Mycology Research Guide